FHL3 and pancreatic ductal adenocarcinoma: FHL3 serves as a binding partner of GSK3β and facilitates tumor metastasis in Pancreatic Ductal Adenocarcinoma (PDAC) by impeding the ubiquitin-mediated degradation of snail1 and twist143.